40th Annual J.P. Morgan Healthcare Conference Presentation slide image

40th Annual J.P. Morgan Healthcare Conference Presentation

R&D Fuels First-to-Market Innovation and Technology Leadership ● ● First-to-Market TFDF® (Tangential Flow Depth Filtration) FlowVPX® In-line process analytics Cal FlowVPX REPLIDEN R REPLIGEN { REPLIGEN Kifle IF Ser REPLIGEN W SELIER ● ● ● Technology Leadership Perfusion and process intensification Harvest/clarification Pre-packed columns Viral vector process optimization Best-in-class affinity ligands In-line process analytics REPLISEN REPLIGEN Chinchpo REPLIGEN REPLIGEN OPUS 45R Key Partnerships Navigo Proteins GmbH High performance affinity ligands Purolite Next-generation Protein A resins Oxford Biomedica Viral vector manufacturing with TFDFⓇ - Ly SPECIFICATIONE Logembant REPLIGEN D r Cur 10
View entire presentation